Ibu-Lysin Heumann (Ibuprofen Lysine)

Ibuprofen lysine works by non‑selectively inhibiting the cyclo‑oxygenase enzymes COX‑1 and COX‑2, which are essential for prostaglandin production. Lower prostaglandin levels reduce inflammation, pain signaling, and fever generation, providing the therapeutic effects associated with NSAIDs.

The appropriate dose of Ibu-Lysin Heumann is determined by the prescribing clinician based on the patient’s age, weight, medical condition, and response to therapy. Healthcare providers follow established guidelines for ibuprofen lysine dosing and adjust as needed for safety and efficacy.

Ibuprofen lysine is generally avoided in the third trimester of pregnancy because of potential risks to the fetal ductus arteriosus. Use during the first and second trimesters should only occur if clearly needed and after consulting a physician. Limited data are available for breastfeeding, so a risk‑benefit assessment is required.

To request Ibu-Lysin Heumann, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will ask for trade or institutional credentials. The sales team then provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Ibuprofen lysine is a salt form of ibuprofen that may offer faster absorption and onset of action compared with standard ibuprofen tablets. Therapeutic efficacy and safety profiles are similar, but the lysine salt can be advantageous when rapid pain relief is desired. Choice between the two depends on clinical judgment and patient preference.

Ibu-Lysin Heumann should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food; however, taking it with meals or an antacid may reduce gastrointestinal discomfort. Patients should follow the dosing schedule prescribed by their healthcare provider.

Serious risks include gastrointestinal bleeding or ulcer perforation, especially in patients with a history of ulcers or who use anticoagulants. Renal impairment, severe hypersensitivity reactions such as anaphylaxis, and cardiovascular events like myocardial infarction or stroke are also important safety concerns that require monitoring.

Ibu-Lysin Heumann is contraindicated in individuals with known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulceration, severe renal or hepatic disease, and in the third trimester of pregnancy. Caution is also advised for patients with uncontrolled hypertension, heart failure, or those taking certain anticoagulants.